DENTSPLY Sirona Inc [XRAY] stock prices are up 2.00% to $13.28 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The XRAY shares have gain 5.82% over the last week, with a monthly amount drifted -15.95%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
DENTSPLY Sirona Inc [NASDAQ: XRAY] stock has seen the most recent analyst activity on April 15, 2025, when Morgan Stanley downgraded its rating to a Equal-Weight but kept the price target unchanged to $14 for it. Previously, Needham downgraded its rating to Hold on March 13, 2025. On February 14, 2025, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $20 on the stock. Jefferies downgraded its rating to a Hold and decreased its price target to $20 on January 23, 2025. Evercore ISI downgraded its rating to a In-line but $20 remained the price target by the analyst firm on January 07, 2025. Mizuho started tracking with a Neutral rating for this stock on December 04, 2024, and assigned it a price target of $21. In a note dated November 07, 2024, Leerink Partners downgraded an Market Perform rating on this stock.
The stock price of DENTSPLY Sirona Inc [XRAY] has been fluctuating between $12.16 and $31.00 over the past year. Currently, Wall Street analysts expect the stock to reach $17.67 within the next 12 months. DENTSPLY Sirona Inc [NASDAQ: XRAY] shares were valued at $13.28 at the most recent close of the market. An investor can expect a potential return of 33.06% based on the average XRAY price forecast.
Analyzing the XRAY fundamentals
The DENTSPLY Sirona Inc [NASDAQ:XRAY] reported sales of 3.79B for trailing twelve months, representing a drop of -10.57%. Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -0.23%, Pretax Profit Margin comes in at -0.25%, and Net Profit Margin reading is -0.24%. To continue investigating profitability, this company’s Return on Assets is posted at -0.16, Equity is -0.34 and Total Capital is -0.21. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.15.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.06 points at the first support level, and at 12.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.67, and for the 2nd resistance point, it is at 14.05.
Ratios To Look Out For
It’s worth pointing out that DENTSPLY Sirona Inc [NASDAQ:XRAY]’s Current Ratio is 1.10. As well, the Quick Ratio is 0.74, while the Cash Ratio is 0.17. Considering the valuation of this stock, the price to sales ratio is 0.68, the price to book ratio is 1.36.
Transactions by insiders
Recent insider trading involved LUCIER GREGORY T, Director, that happened on Mar 03 ’25 when 15142.0 shares were purchased. Former Officer, Coleman Glenn completed a deal on Jan 27 ’25 to buy 15759.0 shares. Meanwhile, Director LUCIER GREGORY T bought 5000.0 shares on Nov 18 ’24.
